MedTech Dive March 4, 2024
The company expects to divest its largest segment, whether through a spinoff or a sale, in the second half of the year.
Dive Brief:
- Baxter International is considering selling its kidney care business instead of spinning it out.
- The company disclosed in a U.S. Securities and Exchange Commission filing on Monday that it had been in recent discussions with private equity investors about a potential sale of the segment.
- Whether through a spinoff or sale, Baxter plans to separate its kidney care segment in the second half of 2024.
Dive Insight:
Baxter first announced plans last year to spin out its renal care and acute therapies businesses into...
Today's Sponsors
Today's Sponsor